Astria Therapeutics - 53 Year Dividend History | ATXS

Historical dividend payout and yield for Astria Therapeutics (ATXS) since 1971. The current TTM dividend payout for Astria Therapeutics (ATXS) as of April 12, 2024 is $0.00. The current dividend yield for Astria Therapeutics as of April 12, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.594B $0.000B
Astria Therapeutics is a biopharmaceutical company which focuses on therapies to treat allergic and immunological diseases. The company's program include STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Astria Therapeutics, formerly known as Catabasis Pharmaceuticals Inc., is based in BOSTON.
Stock Name Country Market Cap PE Ratio